ARTICLE | Company News
King, Merck KGaA sales and marketing update
November 2, 2009 8:00 AM UTC
Merck's Merck Sante S.A.S. subsidiary granted King exclusive rights to commercialize Cyanokit hydroxocobalamin in the U.S., where it is approved to treat known or suspected cyanide poisoning. King sa...